FAL
TAK icon

Focused Alpha LLC’s Takeda Pharmaceutical TAK Stock Holding History

Focused Alpha LLC’s Portfolio TAK Stock Details TAK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$303K Buy
18,897
+2,091
+12% +$34.6K 0.08% 222
2026
Q1 		$311K Buy
16,806
+2,626
+19% +$46.1K 0.1% 205
2025
Q4 		$221K Buy
+14,180
New +$203K 0.07% 228

Other funds holding TAK

Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
BIP
Brandes Investment Partners La Jolla, California $14.3B AUM 23.11% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Qube Research & Technologies (QRT)
Qube Research & Technologies (QRT) London, United Kingdom $108B AUM 37.29% 1-Year Est. Return

Focused Alpha LLC's TAK Position: Q2 2026 in Review

Focused Alpha LLC increased its Takeda Pharmaceutical (TAK) stake by 12% in Q2 2026, buying an estimated $34.6K and bringing the position to 18,897 shares worth $303K. The position accounts for 0.08% of the portfolio, ranked #222.

Focused Alpha LLC first reported a position in TAK in Q4 2025 and has held it in 3 quarters since. The position peaked at $311K in Q1 2026. 376 funds tracked by Wall St. Rank hold TAK as of Q2 2026.

  • Focused Alpha LLC held 18,897 shares of Takeda Pharmaceutical worth $303K as of Q2 2026.
  • Focused Alpha LLC bought 2,091 Takeda Pharmaceutical shares in Q2 2026, an estimated $34.6K.
  • Takeda Pharmaceutical made up 0.08% of Focused Alpha LLC's portfolio in Q2 2026, its #222 holding.
  • Focused Alpha LLC first reported a position in Takeda Pharmaceutical in Q4 2025 and has held it in 3 quarters since.
  • Focused Alpha LLC's Takeda Pharmaceutical position peaked at $311K in Q1 2026.
  • 376 funds tracked by Wall St. Rank held Takeda Pharmaceutical as of Q2 2026.

Based on Focused Alpha LLC's 13F filing for Q2 2026, filed 7 Aug 2026.